News
Failed Alzheimer’s Drug May Hold Promise for Treating Glioblastoma
11/22/2021
Dr. Bao’s team found that treating preclinical models of glioblastoma with verubecestat, a BACE1-inhibiting drug, reduces cancer progression by targeting a class of immune cells abundant in tumors.
Read More
COVID-19 Infection During Pregnancy Leads to Distinct Immune Changes in Mothers and Babies
11/19/2021
Dr. Jung’s team studied blood samples collected from mothers with COVID-19 and their infant children who were exposed to SARS-CoV-2 to understand how infection modulates the expression of different inflammatory molecules.
Read More
New NIH Grant to Study the Effect of Alcohol on Sepsis
11/08/2021
Dr. Vachharajani and her team will study the immuno-metabolic mechanisms that trigger dysfunction in alcohol consumption with sepsis to identify new therapeutic targets for expanded treatments.
Read MoreNew Global Center for Pathogen and Human Health Research
The Global Center for Pathogen and Human Health Research will bring together a research team to broaden understanding of viral pathogens and the human immune response toward preparing and protecting against future public health threats.
LEARN MORE
Accelerating Discoveries to Patients
Working together with Cleveland Clinic physicians, our scientists are discovering the treatments of tomorrow. While many spend their days working at the laboratory bench, their inspiration can be found at the patient bedside.
Education & Training
Postdoctoral Program
Train on the cutting-edge of research and join our thriving postdoc association.
Learn MoreMolecular Medicine PhD Program
Earn your PhD through our unique program that combines basic science and medical knowledge.
Learn More